IS IT ethical to administer an experimental COVID-19 vaccine to a healthy person and then infect him/her with the novel coronavirus to check if the vaccine has immunised the individual against the pathogen? The question is at the centre of a global debate ever since the UK allowed a study, called human challenge trial (HCT), on a COVID-19 vaccine which will be conducted in January 2021.
Normally, a vaccine goes through three phases of human trials. The first phase tests for safety, the second immunogenicity (ability to trigger immune response) and the third involves large-scale testing on tens of thousands of participants of varied populations, who are injected with the vaccine and observed over a long period, even years, for efficacy. In HCT, instead of the third phase trial, a small number of healthy participants (often less than 100) are recruited, at times for money, and administered the vaccine before being injected with a less virulent strain of the virus. HCT thus reduces the trial period by months. The danger, however, is that the injected virus may cause severe illness or even death of the participants during the study.
HCT is not a new concept. It was used for the development of anti-malarial and cholera vaccines in the 1970s. But when HCT was undertaken to develop vaccines for these diseases, drugs to treat them were already there. If a participant became ill, there was a cure available. This is not the case with COVID-19, because there is no guaranteed cure.
ãã®èšäºã¯ Down To Earth ã® October 16, 2020 çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã9,000 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã ?  ãµã€ã³ã€ã³
ãã®èšäºã¯ Down To Earth ã® October 16, 2020 çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã9,000 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã? ãµã€ã³ã€ã³
Trade On Emissions
EU's Carbon Border Adjustment Mechanism, a tariff on imports, is designed to protect European industries in the guise of climate action.
'The project will facilitate physical and cultural decimation of indigenous people'
The Great Nicobar Project has all the hallmarks of a disaster-seismic, ecological, human. Why did it get the go-ahead?
TASTE IT RED
Popularity of Karnataka's red jackfruit shows how biodiversity can be conserved by ensuring that communities benefit from it
MANY MYTHS OF CHIPKO
Misconceptions about the Chipko movement have overshadowed its true objectives.
The politics and economics of mpox
Africa's mpox epidemic stems from delayed responses, neglect of its health risks and the stark vaccine apartheid
Emerging risks
Even as the world gets set to eliminate substances threatening the ozone layer, climate change and space advancement pose new challenges.
JOINING THE CARBON CLUB
India's carbon market will soon be a reality, but will it fulfil its aim of reducing emissions? A report by PARTH KUMAR and MANAS AGRAWAL
Turn a new leaf
Scientists join hands to predict climate future of India's tropical forests
Festering troubles
The Democratic Republic of Congo struggles to contain mpox amid vaccine delays, conflict and fragile healthcare.
India sees unusual monsoon patterns
THE 2024 southwest monsoon has, between June 1 and September 1, led to excess rainfall in western and southern states such as Gujarat, Maharashtra and Tamil Nadu, while others like Nagaland, Manipur and Punjab recorded a deficit.